Letter to the Editor: TMA Endorses SGR Repeal Bill

Translate to Spanish or other 102 languages!

Austin I. King, President Texas Medical Association
Austin I. King, President Texas Medical Association

Mega Doctor News

- Advertisement -

“Today, we begin a massive grassroots campaign for Texas physicians to demand that Congress pass this bill”

By Austin I. King, MD

“On behalf of our 48,000-plus physician and medical student members — and the patients we serve — the Texas Medical Association strongly endorses HR 1470, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015, to repeal and replace Medicare’s Sustainable Growth Rate (SGR) formula.

- Advertisement -

“The SGR has never worked to hold down Medicare costs. It has only served to anger and frustrate physicians and scare our patients. That’s why doing away with the SGR has been at the top of our congressional agenda for more than a decade.

“We applaud Reps. Michael Burgess, MD (R-Lewisville), Kevin Brady (R-The Woodlands), Gene Green (D-Houston), and their Republican and Democratic partners in both the House and the Senate for their hard work in crafting this bill over the past two years.

“Today, we begin a massive grassroots campaign for Texas physicians to demand that Congress pass this bill — and that President Obama sign it — before the 22.4-percent Medicare cut kicks in on April 1.

“Physicians are tired of the never-ending uncertainty; the never-ending threats to cut Medicare pay; the never-ending need to lobby Congress on the same, never-ending problem. Our patients are tired of the never-ending fear of losing their doctor. Eighteen years and 17 patches is enough.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Researchers Discover How Aggressive Brain Tumors Outsmart Treatment

For patients diagnosed with IDH-mutant glioma, an incurable brain tumor that often affects adults in their 30s and 40s, treatment typically works at first. However, the cancer almost always returns, and when it does, it frequently stops responding to treatment.

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -